申请人:——
公开号:US20030216450A1
公开(公告)日:2003-11-20
Compounds according to general formula (1), wherein R
1
is H or CN, X
1
is S, O, SO
2
or CH
2
, X
2
is O, S or CH
2
, X
3
is NR
5
or a carbonyl or thiocarbonyl group and R
4
is R
6
R
7
N, R
8
(CH
2
)
q
OC(═O), R
8
(CH
2
)
q
OC(═S), R
6
R
7
NC(═O), R
6
R
7
NC(═S); R
8
(CH
2
)
q
C(═O), R
8
(CH
2
)
q
C(═S) or R
8
(CH
2
)
q
SO
2
, m is 1-3 and n is 0-4 are new. The compounds of the invention are inhibitors of dipeptidyl peptidase IV. Pharmaceutical compositions of the compounds of the invention, or pharmaceutically acceptable salts thereof, are useful in the treatment of,inter alia, type 2 diabetes.
根据通用公式(1),化合物中R1为H或CN,X1为S、O、SO2或CH2,X2为O、S或CH2,X3为NR5或羰基或硫代羰基基团,R4为R6R7N、R8(CH2)qOC(═O)、R8(CH2)qOC(═S)、R6R7NC(═O)、R6R7NC(═S);R8(CH2)qC(═O)、R8(CH2)qC(═S)或R8(CH2)qSO2,m为1-3,n为0-4的新化合物。该发明的化合物是二肽基肽酶IV的抑制剂。该发明的化合物的药用组合物或其药用盐在治疗2型糖尿病等疾病中有用。